Galmed Pharmaceuticals Ltd. (GLMD)
NASDAQ: GLMD · Real-Time Price · USD
0.6700
+0.0046 (0.69%)
At close: Feb 3, 2026, 4:00 PM EST
0.7000
+0.0300 (4.48%)
After-hours: Feb 3, 2026, 5:09 PM EST
Galmed Pharmaceuticals Market Cap
Galmed Pharmaceuticals has a market cap or net worth of $3.67 million as of February 3, 2026. Its market cap has decreased by -16.57% in one year.
Market Cap
3.67M
Enterprise Value
-15.38M
1-Year Change
-16.57%
Ranking
Category
Stock Price
$0.67
Market Cap Chart
Since March 13, 2014, Galmed Pharmaceuticals's market cap has decreased from $145.70M to $3.67M, a decrease of -97.48%. That is a compound annual growth rate of -26.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 3.70M | -9.76% |
| Dec 31, 2025 | 4.10M | -14.58% |
| Dec 31, 2024 | 4.80M | 166.67% |
| Dec 29, 2023 | 1.80M | -85.71% |
| Dec 30, 2022 | 12.60M | -72.43% |
| Dec 31, 2021 | 45.70M | -30.44% |
| Dec 31, 2020 | 65.70M | -45.93% |
| Dec 31, 2019 | 121.50M | 23.23% |
| Dec 31, 2018 | 98.60M | -11.33% |
| Dec 29, 2017 | 111.20M | 185.13% |
| Dec 30, 2016 | 39.00M | -53.85% |
| Dec 31, 2015 | 84.50M | 42.98% |
| Dec 31, 2014 | 59.10M | -59.44% |
| Mar 13, 2014 | 145.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silo Pharma | 4.60M |
| PMGC Holdings | 4.16M |
| Psyence Biomedical | 4.09M |
| Enveric Biosciences | 4.05M |
| Matinas BioPharma Holdings | 3.83M |
| Oragenics | 3.59M |
| XORTX Therapeutics | 3.54M |
| CNS Pharmaceuticals | 3.46M |